Regulated expression of the diphtheria toxin A gene in human glioma cells using prokaryotic transcriptional control elements

Journal of Neurosurgery

Volumn 87, Issue 1, 1997, Pages 89-95

  Paulus, Werner ^a   Baur, Inge ^b   Oberer, Daniel M ^b   Breakefield, Xandra O ^b   Reeves, Steven A ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Diphtheria toxin; Gene therapy; Glioblastoma multiforme; Lac system; Tet system; Tetracycline

Indexed keywords

ARTICLE; CANCER CELL CULTURE; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE LOCATION; GENE THERAPY; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0030925087     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.1.0089     Document Type: Article

References (38)

1. Arnosti DN, Preston CM, Hagmann M, et al: Specific transcriptional activation in vitro by the herpes simplex virus protein VP16. Nucl Acids Res 21:5570-5576, 1993
2. Bi WL, Parysek LM, Warnick R, et al: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 4:725-731, 1993
3. Brown M, Figge J, Hansen U, et al: lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell 49:603-612, 1987
4. Colombo BM, Benedetti S, Ottolenghi S, et al: The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6:763-772, 1995
5. Culver KW, Blaese RM: Gene therapy for cancer. Trends Genet 10:174-178, 1994
6. Daniel PT, Krammer PH: Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 152:5624-5632, 1994
7. Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543, 1993
8. Frankel AE, Tagge EP, Willingham MC: Clinical trials of targeted toxins. Semin Cancer Biol 6:307-317, 1995
9. Freeman SM, Abboud CN, Whartenby KA, et al: The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53:5274-5283, 1993
10. Furth PA, Onge LS, Böger H, et al: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91:9302-9306, 1994
11. Gossen M, Bonin AL, Bujard H: Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 18:471-175, 1993
12. Gossen M, Bujard H: Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucl Acids Res 21:4411-4412, 1993
13. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551, 1992
14. Graycar JL, Miller DA, Arrick BA, et al: Human transforming growth factor-β 3: recombinant expression, purification, and biological activities in comparison with transforming; growth factors-β 1 and -β 2. Mol Endocrinol 3:1977-1986, 1989
15. Hannan GN, Lehnert SA, MacAvoy ES, et al: An engineered PGK promoter and lac operator-repressor system for the regulation of gene expression in mammalian cells. Gene 130: 233-239, 1993
16. Harlow E, Lane D (eds): Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988
17. Henson J, Saffer J, Furneaux H: The transcription factor Sp1 binds to the JC virus promotor and is selectively expressed in glial cells in human brain. Ann Neurol 32:72-77, 1992
18. Hillen W, Berens C: Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu Rev Microbiol 48:345-369, 1994
19. Hu MCT, Davidson N: The inducible lac operator-repressor system is functional in mammalian cells. Cell 48:555-566, 1987
20. Karpati G, Lochmüller H, Nalbantoglu J, et al: The principles of gene therapy for the nervous system. Trends Neurosci 19: 49-54, 1996
21. Kochi SK, Collier RJ: DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp Cell Res 208:296-302, 1993
22. Kramm CM, Sena-Esteves M, Barnett FH, et al: Gene therapy for brain tumors. Brain Pathol 5:345-381, 1995
23. Madshus IH: The N-terminal α-helix of fragment B of diphtheria toxin promotes translocation of fragment A into the cytoplasm of eukaryotic cells. J Biol Chem 269:17723-17729, 1994
24. Maxwell IH, Glode LM, Maxwell F: Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells. Cancer Res 51: 4299-4304, 1991
25. Maxwell IH, Harrison GS, Wood WM, et al: A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. Biotechniques 7:276-280, 1989
26. Maxwell IH, Maxwell F, Glode LM: Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide. Cancer Res 46:4660-4664, 1986
27. Mizuguchi H, Nakanishi M, Nakanishi T, et al: Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy. Br J Cancer 73:472-476, 1996
28. Morimoto H, Bonavida B: Diphtheria toxin-and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-α. J Immunol 149: 2089-2094, 1992
29. Mulligan RC: The basic science of gene therapy. Science 260: 926-932, 1993
30. Naglich JG, Metherall JE, Russell DW, et al: Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69:1051-1061, 1992
31. Pai LH, Pastan I: Immunotoxins and recombinant toxins for cancer treatment. Important Adv Oncol:3-19, 1994
32. Passador L, Iglewski W: ADP-ribosylating toxins. Methods Enzymol 235:617-631, 1994
33. Paulus W, Baur I, Boyce FM, et al: Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 70:62-67, 1996
34. Ramesh V, McClatchey AI, Ramesh N, et al: Molecular basis of ornithine aminotransferase deficiency in B-6-responswe and -nonresponsive forms of gyrate atrophy. Proc Natl Acad Sci USA 85:3777-3780, 1988
35. Samejima Y, Meruelo D: Bystander killing induces apoptosis and is inhibited by forskolin. Gene Ther 2:50-58, 1995
36. Sauer RT: Lac repressor at last. Structure 4:219-222, 1996
37. Yamaizumi M, Mekada E, Uchida T, et al: One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15:245-250, 1978
38. Yu JS, Sena-Esteves M, Paulus W, et al: Retroviral delivery and tetracycline-dependent expression of IL-1β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res 56:5423-5427, 1996